COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 311: Articles 3101-3110  | Next

Pathway-enhanced Transformer-based model for robust enumeration of cell types from the cell-free transcriptome
Yan, S., Tian, X., Qin, Y., Li, J., Yang, T., Yu, D., Liu, W., Sun, J., Hu, C., Zhou, Q., Liu, Z., Wang, W.-J.
10.1101/2024.02.28.582494 — Posted: 2024-02-28
Virological traits of the SARS-CoV-2 BA.2.87.1 lineage
Zhang, L., Dopfer-Jablonka, A., Nehlmeier, I., Kempf, A., Graichen, L., Calderon Hampel, N., Cossmann, A., Stankov, M. V., Morillas Ramos, G., Schulz, S. R., Jaeck, H.-M., Behrens, G. M. N., Poehlmann, S., Hoffmann, M.
10.1101/2024.02.27.582254 — Posted: 2024-02-28
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Guenthoer, J., Garrett, M. E., Lilly, M., Depierreux, D. M., Ruiz, F., Chi, M., Stoddard, C. I., Chohan, V., Sung, K., Ralph, D., Chu, H. Y., Matsen, F. A., Overbaugh, J.
10.1101/2024.02.26.582219 — Posted: 2024-02-28
The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in infected and immune suppressed mice
Penrice-Randal, R., Bentley, E. G., Sharma, P., Kirby, A., Donovan-Banfield, I., Kipar, A., Mega, D. F., Bramwell, C., Sharp, J., Owen, A., Hiscox, J. A., Stewart, J. P.
10.1101/2024.02.27.582110 — Posted: 2024-02-28
Carboxylated graphene: A novel approach for enhanced IgA-SARS-CoV-2 electrochemical biosensing
Freire, L. d. S., Ruzo, C. M., Salgado, B. B., Gandarilla, A., Barcelay, Y. R., Tavares, A. P. M., Nobre, F. X., Lalwani, P., Astofi-Filho, S., Brito, W.
10.1101/2024.02.27.582131 — Posted: 2024-02-28
Secondary structure of the SARS-CoV-2 genome is predictive of nucleotide substitution frequency
Hensel, Z.
10.1101/2024.02.27.581995 — Posted: 2024-02-28
Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiome
Bontempo, A., Chirino, A., Heidari, A., Lugo, A., Shindo, S., Pastore, M. R., Antonson, S., Godoy, C., Nichols, F., Potempa, J., Davey, M., Kawai, T., Cayabyab, M.
10.1101/2024.02.27.582258 — Posted: 2024-02-28
Designed mosaic nanoparticles enhance cross-reactive immune responses in mice
Wang, E., Cohen, A. A., Caldera, L. F., Keeffe, J. R., Rorick, A. V., Aida, Y. M., Gnanapragasam, P. N. P., Bjorkman, P. J., Chakraborty, A. K.
10.1101/2024.02.28.582544 — Posted: 2024-02-28
Attenuated replication and damaging effects of SARS-CoV-2 Omicron in an intestinal epithelial barrier model
Volcic, M., Nchioua, R., Pastorio, C., Zech, F., Read, C., Walther, P., Kirchhoff, F.
10.1101/2024.02.28.582510 — Posted: 2024-02-28
Telemedicine's Impact on Diabetes Care during the COVID-19 Pandemic: A Cohort Study in a Large Integrated Healthcare System
Patel, R., Huang, J., Hsueh, L., Gopalan, A., Millman, A., Franklin, I., Reed, M.
10.1101/2024.02.25.24303335 — Posted: 2024-02-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).